
-
03/31/2023
PAION AG implements resolved capital reduction
-
03/30/2023
PAION AG reports on fiscal year 2022
-
03/16/2023
PAION IS HOSTING A SPONSORED ANGIOTENSIN II SYMPOSIUM AT ISICEM IN BRUSSELS
-
01/25/2023
Extraordinary General Meeting approves capital reductions and creates scope for further corporate financing
-
01/25/2023
PAION AG: Extraordinary General Meeting approves capital reductions and creates scope for further corporate financing
-
01/19/2023
PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE CRISTÁLIA IN BRASIL